| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 |
Celcuity Inc
CELC
|
BUY |
$122.00
Est. +5%
|
$115.94 | $151.02 |
Target Met
|
$88.55
-23.6%
|
| Dec 04, 2025 |
Solid Biosciences Inc
SLDB
|
BUY |
$16.00
Est. +208%
|
$5.19 | $8.87 |
Pending
|
$7.14
+37.6%
|
| Oct 02, 2025 |
Taysha Gene Therapies Inc
TSHA
|
BUY |
$10.00
Est. +110%
|
$4.77 | $7.30 |
Pending
|
$5.71
+19.7%
|
| Jul 10, 2025 |
Mereo Biopharma Group Plc - ADR
MREO
|
BUY |
$5.00
Est. +167%
|
$1.87 | $2.37 |
Pending
|
$0.31
-83.7%
|
| Nov 27, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$202.00
Est. +48%
|
$136.87 | $138.69 |
Miss
|
$15.31
-88.8%
|
| Sep 04, 2024 |
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
RXRX
|
BUY |
$11.00
Est. +80%
|
$6.10 | $12.36 |
Target Met
|
$3.15
-48.4%
|
| Aug 13, 2024 |
Artiva Biotherapeutics Inc
ARTV
|
BUY |
$23.00
Est. +105%
|
$11.22 | $17.31 |
Miss
|
$8.54
-23.9%
|
| Aug 06, 2024 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$84.00
Est. +68%
|
$50.11 | $71.13 |
Miss
|
$49.80
-0.6%
|
| Jun 25, 2024 |
G1 Therapeutics Inc
GTHX
|
BUY |
$6.00
Est. +170%
|
$2.22 | $7.19 |
Target Met
|
$7.16
+222.5%
|
| Jun 12, 2024 |
Mereo Biopharma Group Plc - ADR
MREO
|
BUY |
$7.00
Est. +99%
|
$3.52 | $5.02 |
Miss
|
$0.31
-91.3%
|
| Mar 28, 2024 |
Celcuity Inc
CELC
|
BUY |
$24.00
Est. +32%
|
$18.16 | $19.77 |
Miss
|
$88.55
+387.6%
|
| Mar 28, 2024 |
Mereo Biopharma Group Plc - ADR
MREO
|
BUY |
$6.00
Est. +100%
|
$3.00 | $5.02 |
Miss
|
$0.31
-89.8%
|
| Mar 22, 2024 |
Nkarta Inc
NKTX
|
BUY |
$15.00
Est. +16%
|
$12.98 | $8.23 |
Miss
|
$2.86
-78.0%
|
| Mar 18, 2024 |
Arcellx Inc
ACLX
|
BUY |
$81.00
Est. +17%
|
$69.11 | $107.37 |
Target Met
|
$115.07
+66.5%
|
| Mar 15, 2024 |
Geron Corp.
GERN
|
BUY |
$5.00
Est. +49%
|
$3.36 | $5.06 |
Precision Hit (±3%)
|
$1.15
-65.8%
|
| Nov 03, 2022 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$158.00
Est. +50%
|
$105.01 | - | - |
$15.31
-85.4%
|
| Mar 02, 2022 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$150.00
Est. +89%
|
$79.56 | - | - |
$15.31
-80.8%
|
| Feb 16, 2022 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$170.00
Est. +174%
|
$61.97 | - | - |
$49.80
-19.6%
|